FGFR3 and hepatocellular carcinoma: Aberrant splicing of the FGFR3 transcript has been shown to promote HCC malignancy by modifying its ligand-binding domain, enabling self-activation via homodimerization and autophosphorylation, even in the absence of a ligand [39].